Add-Aspirin Trial - Breast

Trial description
A phase III, double blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours
Contact name
Dr Luke Hughes-Davies
Trial start date
Monday, December 21, 2015
Trial end date
Friday, December 11, 2020
Trial tumour type
Breast
Colorectal
Oesophageal
Prostate
Show on Radiotherapy
No